Interleukin-10 inhibits human vascular smooth muscle proliferation

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 4, 1998, Pages 889-896

  Selzman, Craig H ^a,b   McIntyre Jr , Robert C ^a   Shames, Brian D ^a   Whitehill, Thomas A ^a   Banerjee, Anirban ^a   Harken, Alden H ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Atherosclerosis; Cytokines; Fibroblast growth factor; Interleukin 10; Tumor necrosis factor; Vascular smooth muscle

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CYTOKINE; GROWTH FACTOR; INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

AORTA; ARTERY INJURY; ARTICLE; CELL GROWTH; CELL ISOLATION; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS; HEART CELL CULTURE; HUMAN; HUMAN CELL; MACROPHAGE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; STENOSIS; T LYMPHOCYTE; VASCULAR SMOOTH MUSCLE;

EID: 0032053484     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0642     Document Type: Article

References (34)

1. BACH EA, AGUET M, SCHREIBER RD, 1997. The IFNγ receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol 15: 563-591.
2. BAKER SJ, REIDY EP, 1996. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12: 1-9.
3. BARATH P, FISHBEIN BC, CAO H, BERENSON J, HELEANT RH, FORRESTER JS, 1990. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 65: 297-302.
4. CHADBAN SJ, TESCH GH, FOTI R, ATKINS RC, NIKOLIC-PATERSON DJ, 1997. Interleukin-10 is a mesangial cell growth factor in vitro and in vivo. Lab Invest 76: 619.
5. DOKTER WHA, KOOPMANS SB, VELLENGA E, 1996. Effects of IL-10 and IL-4 on LPS-induced transcription factors (AP-1, NF-IL6, and NF-κB) which are involved in IL-6 regulation. Leukemia 10: 1308-1316.
6. ENGLES TE, HUBER TS, ZANDER DS, HESS PJ, WELBORN MB, MOLDAWER LL, SEEGER JM, 1997. Exogenous human recombinant interleukin-10 attenuates hindlimb ischemia-reperfusion injury. J Surg Res 69: 425-428.
7. FINBLOOM DS, WINESTOCK KD, 1995. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1a and STAT3 complexes in human T cells and monocytes. J Immunol 155: 1079-1090.
8. FRIESEL RE, MACIAG T, 1995. Molecular mechanisms of angiogenesis: flbroblast growth factor signal transduction. FASEB J 9: 919-925.
9. FUCHS AC, GRANOWITZ EV, SHAPIRO L, VANNIER E, LONNEMANN G, ANGEL JB, KENNEDY J, RABSON AR, RADWANSKI E, AFFRIME MB, CUTLER DL, GRINT PC, DINARELLO CA, 1996. Clinical, hematologic, and immunologic effects of interleukin-10 in humans. J Clin Immunol 16: 291-303.
10. GU ZJ, COSTES V, LU ZH, ZHANG XG, PITARD V, MOREAU JF, BATAILLE R, WIJDENES J, ROSSI JF, KLEIN B, 1996. Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop. Blood 88: 3972-3986.
11. HANSSON GK, JONASSON L, LOJSTHED B, STEMME S, KOCHER O, GABBIANI G, 1988. Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Atherosclerosis 72: 135-141.
12. HO ASY, LIU Y, KHAN TA, HSU DH, BAZAN JF, MOORE KW, 1993. A receptor for interleukin 10 is related to interferon receptors. Proc Natl Acad Sci USA 90: 11267-11271.
13. HODGES-GARCIA Y, MADIGAN N, HORWITZ LC, 1998. Primary human vascular smooth muscle cell culture enhanced by human umbilical cord serum. In Vitro Cell Develop Biol (In press).
14. HOWARD M, MUCHAMUEL T, ANDRADE S, MENON S, 1993. Interleukin-10 protects mice from lethal endotoxemia. J Exp Med 177: 1205-1208.
15. HUGHES SE, CROSSMAN D, HALL PA, 1993. Expression of basic and acidic flbroblast growth factors and their receptors in normal and atherosclerotic human arteries. Cardiovasc Res 27: 1214-1219.
16. JOHNSON RJ, LIDA H, ALPERS CE, MAJESKY WM, SCHWARTZ SM, PRITZL P, GORDON K, 1991. Expression of smooth muscle cell phenotype by rat mesangeial cells in immune complex nephritis. J Clin Invest 87: 847-858.
17. JONASSON L, HOLM J, SKALLI O, GABBIANI G, HANSSON GK, 1985. Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis. J Clin Invest 76: 125-131.
18. KITAMURA T, TANGE T, TERASAWA T, CHIBA S, KUWAKI T, MIYAGAWA K, PIAO YF, MIYAZONO K, URABE A, TAKAKU F, 1989. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J Cell Physiol 140: 323-334.
19. LANE JS, TODD KE, LEWIS MPN, GLOOR B, ACHLEY SW, REBER HA, MCFADDEN DW, CHANDLER CF, 1997. Interleukin-10 reduces the systemic inflammatory response in a murine model of intestinal ischemia/reperfusion. Surgery 122: 288-294.
20. MARCHANT A, DEVIERE J, BYL B, DE GROOTE D, VINCENT JL, GOLDMAN M, 1994. Interleukin-10 production during septicaemia. Lancet 343: 707-708.
21. MARRIOT JB, GOLDMAN JH, KEELING PJ, BAIG MK, DALGLEISH AG, MCKENNA WJ, 1996. Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives. Heart 75: 287-290.
22. MOSMANN T, 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63.
23. PAJKRT D, CAMOGLIO L, TIEL-VAN BUUL MCM, DE BRUIN K, CUTLER DL, AFFRIME MB, RIKKEN G, VAN DER POLL T, WOUTER TEN CATE J, VAN DEVENTER SJH, 1997. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J Immunol 158: 3971-3977.
24. RAMSHAW AL, PARUMS DV, 1990. Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis. Histopathology 17: 543-552.
25. REIDY MA, 1993. Neointimal proliferation: the role of basic FGF on vascular smooth muscle cell proliferation. Thromb Haemost 70: 172-176.
26. ROSS R, 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
27. ROUSSET R, GARCIA E, DEFRANCE T, PERONNE C, VEZZIO N, HSU DH, KASTELEIN RD, MOORE KW, BANCHEREAU J, 1992. Interleukin-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89: 1890-1893.
28. SAWA T, CORRY DB, GROPPER MA, OHARA M, KURAHASHI K, WIENER-KRONISH JP, 1997. IL-10 improves lung injury and survival in pseudomonas aeruginosa pneumonia. J Immunol 159: 2858-2866.
29. SHIBATA M, ENDO S, INADA K, KURKIK S, HARADA M, TAKING T, SATO N, ARAKAWA N, SUZUKI T, AOKI H, SUZUKI T, HIRAMORI K, 1997. Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res 17: 145-150.
30. STEEME S, JONASSON L, HOLM J, HANSSON GK, 1989. Immunologic control of vascular cell growth in arterial response to injury and atherosclerosis. Transplant Proc 4: 3697-3699.
31. TAKESHITA S, GAGE JR, KISHIMOTO T, VREDEVOE DL, MARTINEZ-MAZA O, 1996. Differential regulation of IL-6 gene transcription and expression by IL-4 and IL-10 in human monocytic cell lines. J Immunol 156: 2591-2598.
32. UYEMURA K, DEMER LL, CASTLE SC, JULLIEN D, BERLINER JA, GATELY MK, WARRIER RR, PHAM N, FOGELMAN AM, MODLIN RL, 1996. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest 97: 2130-2138.
33. WANG P, WU P, SIEGEL MI, EGAN RW, BILLAH MM, 1994. IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 153: 811-816.
34. WANG P, WU P, SIEGEL MI, EGAN RW, BILLAH M, 1995. Interleukin (IL)-10 inhibits nuclear factor κB (NFκB) activation in human monocytes. J Biol Chem 270: 9558-9563.